TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,412,000 | -10.9% | 4,588,500 | -5.6% | 0.01% | -16.7% |
| Q1 2015 | $7,197,000 | -0.3% | 4,863,000 | -8.0% | 0.01% | -14.3% |
| Q4 2014 | $7,218,000 | +1.3% | 5,283,000 | -4.8% | 0.01% | -12.5% |
| Q3 2014 | $7,122,000 | -4.1% | 5,548,000 | -4.5% | 0.01% | -11.1% |
| Q2 2014 | $7,428,000 | -0.6% | 5,812,000 | -1.3% | 0.01% | -10.0% |
| Q1 2014 | $7,475,000 | +21.1% | 5,888,000 | +1.3% | 0.01% | +25.0% |
| Q4 2013 | $6,173,000 | -0.5% | 5,813,000 | -2.8% | 0.01% | -11.1% |
| Q3 2013 | $6,202,000 | -1.9% | 5,981,000 | -0.9% | 0.01% | -10.0% |
| Q2 2013 | $6,319,000 | – | 6,033,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |